- KR₩6tn
- KR₩6tn
- KR₩2tn
S.Korea stocks, won drop on concerns over Trump's trade threat
S.Korea's pharma shrs jump on plans to revise supervisory standards on accounting rules
S.Korea's biopharmaceutical shares fall on dimmer outlook
S.Korea's Hanmi Pharm soars, diabetes drug enters phase 2 clinical trial
Brief: Hanmi Pharm to buy facilities for 113.3 bln won
Brief: Hanmi Science unit Hanmi Pharm says issuance of 728,341 bonus shares
Sanofi sees strong profit growth from 2018, to cut costs (updated)
Sanofi sees strong profit growth from 2018, to cut costs
Sanofi, Hanmi seal diabetes licence deal for up to $4.2 bln (updated)
Sanofi, Hanmi seal diabetes licence deal for up to $4.2 bln (updated)
AstraZeneca says competitor to blockbuster Nexium launched in U.S.
U.S. court temporarily blocks a competitor to AstraZeneca's Nexium